Literature DB >> 5866611

Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine.

J J Schildkraut, E K Gordon, J Durell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5866611     DOI： 10.1016/0022-3956(65)90003-8

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN： 0022-3956            Impact factor:   4.791


× No keyword cloud information.
  17 in total

1.  Molecular epidemiology of major depressive disorder.

Authors:  Chikako Kiyohara; Kouichi Yoshimasu
Journal:  Environ Health Prev Med       Date:  2009-01-20       Impact factor: 3.674

2.  The tyrosine-tryptophan-diagram in a longtime study with depressed patients.

Authors:  P Riederer; W Birkmayer; E Neumayer
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

3.  [Disturbance of tyrosine and tryptophane metabolism in depression].

Authors:  W Birkmayer; W Linauer
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1970

4.  Thyrotropin releasing hormone: neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines.

Authors:  R B Rastogi; R L Singhal; Y D Lapierre
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

Review 5.  Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders.

Authors:  Miguel Pérez de la Mora; Dasiel O Borroto-Escuela; Minerva Crespo-Ramírez; José Del Carmen Rejón-Orantes; Daniel Alejandro Palacios-Lagunas; Magda K Martínez-Mata; Daniela Sánchez-Luna; Emiliano Tesoro-Cruz; Kjell Fuxe
Journal:  Cells       Date:  2022-06-02       Impact factor: 7.666

6.  Effects of a false neurotransmitter, p-hydroxynorephedrine, on the function of adrenergic neurons in hypertensive patients.

Authors:  R E Rangno; J S Kaufmann; J H Cavanaugh; D Island; J T Watson; J Oates
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

7.  Decrease in brain NE turnover after chronic DMI treatment; no effect with iprindole.

Authors:  B N Rosloff; J M Daivis
Journal:  Psychopharmacology (Berl)       Date:  1978-04-11       Impact factor: 4.530

8.  Plasma renin activity in primary and secondary depression.

Authors:  A C Altamura; A Morganti; E Smeraldi; A Zanchetti
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-12-28

Review 9.  Neuropsychiatric disorders related to interferon and interleukins treatment.

Authors:  Aye Mu Myint; Markus J Schwarz; Harry W M Steinbusch; Brian E Leonard
Journal:  Metab Brain Dis       Date:  2008-12-10       Impact factor: 3.584

10.  Antidepressant-Like and Antioxidant Effects of Plinia trunciflora in Mice.

Authors:  Cassia Sacchet; Ricieri Mocelin; Adrieli Sachett; Fernanda Bevilaqua; Rafael Chitolina; Fernanda Kuhn; Aline Augusti Boligon; Margareth Linde Athayde; Walter Antonio Roman Junior; Denis Broock Rosemberg; Jacir Dal Magro; Greicy Michelle Marafiga Conterato; Angelo L Piato
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-02       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.